Hell, Michaela M.
Emrich, Tilman
Lurz, Philipp
von Bardeleben, Ralph Stephan
Schmermund, Axel
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Accepted: 6 November 2023
First Online: 29 November 2023
Declarations
:
: Dr. Emrich reports travel support, speaker fee, advisory board member and institutional research support of Siemens Healthcare. Dr. Lurz reports honoraria from ReCor Medical and Innoventrics and institutional grants from Edwards Lifesciences and ReCor Medical. Dr. von Bardeleben reports speaker or advisory fees from Abbott Cardiovascular, Edwards Lifesciences, Medtronic, NeoChord, Philips, and Siemens Healthcare as well as trial activity unpaid from Abbott Cardiovascular, Edwards Lifesciences, Jenscare, Medtronic, and NeoChord. Dr. Hell and Dr. Schmermund has nothing to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.